2023 / 04

Next Paper
DOI: 10.47183/mes.2023.048

ORIGINAL RESEARCH

Assessment of lipid spectrum and C-reactive protein in people working in the Arctic zone of Russia

Narutdinov DA1, Rakhmanov RS2, Bogomolova ES2, Razgulin SA2, Potekhina NN2
About authors

1 Voino-Yasenetsky Krasnoyarsk Medical University, Krasnoyarsk, Russia

2 Privolzhsky Research Medical University, Nizhny Novgorod, Russia

Correspondence should be addressed: Rofail S. Rakhmanov
ploschad Minina i Pozharskogo, 10/1, Nizhny Novgorod, Russia; ur.liam@35far

About paper

Author contribution: Rakhmanov RS — study design and concept, article authoring; Bogomolova ES — editing, approval of the final version of the article; Narutdinov DA — primary material collection; Razgulin SA — literature analysis; Potekhina NN — participation in statistical processing of the material.

Compliance with the ethical standards: the study was approved by the Ethics Committee of the Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation (Minutes #4 of March 14, 2022); all study participants signed a voluntary informed consent form.

Received: 2023-09-09 Accepted: 2023-11-01 Published online: 2023-11-24
|
  1. Kukharchuk VV, Ezhov MV, Sergienko IV, Arabidze GG, Balakhonova TV, Gurevich VS, et al. Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2020). Eurasian heart journ. 2020; 2: 6–29. DOI: 10.38109/2225-16852020-2-6-29. (Russian).
  2. Utkina EA, Afanasyeva OI, Pokrovsky SN. C-reactive protein: pathogenetic characteristics and possible therapeutic target. Russian Journal of Cardiology. 2021; 26 (6): 4138. DOI: 10.15829/1560-4071-2021-4138. (Russian).
  3. Melnikov IS, Kozlov SG, Saburova OS, Avtaeva YN, Guria KG, Gabbasov ZA. Monomeric C-reactive protein in atherosclerotic cardiovascular disease: advances and perspectives. Int J Mol Sci. 2023 Jan 20; 24 (3): 2079.
  4. Avan A, Tavakoly Sany SB, Ghayour-Mobarhan M, Rahimi HR, Tajfard M, Gordon Ferns G. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice. J Cell Physiol. 2018; 233 (11): 8508–25. DOI:10.1002/jcp.26791.
  5. Shah PK. Inflammation, infection and atherosclerosis. Trends Cardiovasc Med. 2019; 29 (8): 468–72. DOI: 10.1016/j. tcm.2019.01.004.
  6. Adukauskienė D, Čiginskienė A, Adukauskaitė A, Pentiokinienė D, Šlapikas R, Čeponienė I. Clinical relevance of high sensitivity C-reactive protein in cardiology Medicina (Kaunas). 2016; 52 (1): 1–10. DOI: 10.1016/j.medici.2015.12.001.
  7. Nagibovich OA, Ukhovsky DM, Zhekalov AN, et al. Mechanisms of hypoxia in Arctic zone of Russian Federation. Bulletin Of The Russian Military Medical Academy. 2016; 2 (54): 202–5. (Russian).
  8. Sevostyanova YV. Some features of human lipid and carbohydrate metabolism in the North. Bulletin of Siberian Medicine. 2013; 12 (1): 93–100. (Russian).
  9. Kurkatov SV, Tikhonova IV, Ivanova OYu. Assessment of the risk of environmental atmospheric pollutants for the health of the population of the city of Norilsk. Hygiene and Sanitation. 2015; 94 (2): 28–31. (Russian).
  10. Revich BA. Riski zdorov'yu naseleniya v «goryachikh tochkakh» ot khimicheskogo zagryazneniya Arkticheskogo makroregiona. Problemy prognozirovaniya. 2020; 2: 148–57. (Russian).
  11. Hazova EV, Bulashova OV, Amirov NB. Is it necessary to determine highly sensitive C-reactive protein in patients with chronic heart failure: clinical and prognostic aspects. Bulletin of contemporary clinical medicine. 2022; 15 (4): 54–9. DOI: 10.20969/VSKM.2022. (Russian).
  12. Kramer F, Voss S, Roessig L, et al. Evaluation of highsensitivity C-reactive protein and uric acid in vericiguattreated patients with heart failure with reduced ejection fraction. Eur J Heart Fail. 2020; 22 (9): 1675–83. DOI: 10.1002/ejhf.1787.
  13. Postanovlenie Pravitel'stva RF ot 29.12.2007 № 946 (red. ot 18.09.2020) «O prodovol'stvennom obespechenii voennosluzhashchikh i nekotorykh drugikh kategoriy lits, a takzhe ob obespechenii kormami (produktami) shtatnykh zhivotnykh voinskikh chastey i organizatsiy v mirnoe vremya». (Russian).
  14. Federal'nyy zakon ot 13.07.2020 №193-FZ «O gosudarstvennoy podderzhke predprinimatel'skoy deyatel'nosti v Arkticheskoy zone Rossiyskoy Federatsii». (Russian).
  15. Gridin LA, Shishov AA, Dvornikov MV. Features adaptation reactions of human in Far North. Public Health and Life Environment. 2014; 4 (253): 4–6. (Russian).
  16. Deputat IS, Deryabina IN, Nekhoroshkova AN, Gribanov AV. Effect of Climatic and Ecological Conditions of the North on Ageing Processes. Journal of Medical and Biological Research. 2017; 5 (3): 5–17. (Russian).
  17. Chashchin VP, Gudkov AB, Chashchin MV, Popova ON. Predictive Assessment of Individual Human Susceptibility to Damaging Cold Exposure. Human Ecology. 2017; 5: 3–13. (Russian).
  18. Polyakova EM, Chashchin VP, Meltser AV. Risk factors causing health disorders among workers involved in oil extraction and performing their working tasks outdoors during a cold season. Health Risk Analysis. 2019; 4: 84–92. (Russian).
  19. Polyakova EM, Meltser AV. Сomparative analysis of health status of employees working in an open territory in t cold period of the year according to questionnaire results. Preventive and clinical medicine 2019; 4 (73): 35–44. (Russian).
  20. Morris DM, Pilcher JJ, Powell RB. Task-dependent cold stress during expeditions in Antarctic environments. Int J Circumpolar Health. 2017; 76 (1): 1379306. DOI:10.1080/22423982.2017.13 79306.
  21. Gudkov AB, Popova ON, Nebuchennyh AA, Bogdanov MYu. Ecological and physiological characteristic of the Arctic climatic factors. Review. Marine medicine. 2017; 3 (1): 7–13. (Russian).
  22. Panin LE. Lipoprotein metabolism and atherosclerosis. The Siberian Scientific Medical Journal. 2006; 2 (120): 15–22. (Russian).
  23. Krivoshapkina ZN, Mironova GE, Semenova EI, Olesova LD,Yakovleva AI. Pokazateli lipidnogo obmena u prishlykh zhiteley Yakutii v zavisimosti ot srokov prozhivaniya na Severe. Yakutskiy meditsinskiy zhurnal. 2018; 2: 28–30. DOI: 10.25789/ YMJ.2018.62.09. (Russian).
  24. Gurevich VS, Koziolova NA, Ezhov MV, Sergienko IV, Аlieva AS, Vavilova TV, et al. Unsolved problems of dyslipidemia and residual cardiovascular risk. The Journal of Atherosclerosis and Dyslipidemias. 2022; 1 (46): 31–9. DOI: 10.34687/2219-8202.JAD.2022.01.0003. (Russian).
  25. Poteryaeva ON, Usynin IF. Dysfunctional high-density lipoproteins in diabetes mellitus. Problems of Endocrinology. 2022; 68 (4): 69–77. DOI: 10.14341/probl13118. (Russian).
  26. Wong N, Nicholls S, Tan J, Bursill C. The role of high-density lipoproteins in diabetes and its vascular complications. Int J Mol Sci. 2018; 19 (6): 1680. DOI: 10.3390/ijms19061680.
  27. Ageykin AV, Almakaeva AD. Lipoproteidy vysokoy plotnosti kak glavnyy antiaterogennyy faktor razvitiya ateroskleroza. Molodoy uchenyy. 2015; 1 (81): 139–41. (Russian).
  28. Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013 Jul 30; 62 (5): 397–408. DOI: 10.1016/j.jacc.2013.05.016.
  29. Denegri A, Boriani G. High Sensitivity C-reactive Protein (hsCRP) and its Implications in Cardiovascular Outcomes. Curr Pharm Des. 2021; 27 (2): 263–75. DOI: 10.2174/1381612826666200717090334.
  30. Boncler M, Wu Y, Watala C. The Multiple Faces of C-Reactive Protein-Physiological and Pathophysiological Implications in Cardiovascular Disease. Molecules. 2019 May 30; 24 (11): 2062. DOI: 10.3390/molecules24112062.